Neuronet convenes 8th meeting of its Scientific Coordination Board
On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
IM2PACT
Spotlight on early-career researchers: a Neuronet interview with Ilaria Ottonelli
Ilaria Ottonelli studies innovative nanomedicines for brain and retinal targeting at the University of Modena and Reggio Emilia.
Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Apply as researcher in blood-brain barrier pharmacokinetics of biologics as part of the IM2PACT project at Uppsala University
The researcher will be working in the research group of Translational Pharmacokinetics and Pharmacodynamics (tPKPD).
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
Neuronet Scientific Coordination Board meeting brings together project leaders
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.